These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8357180)

  • 21. [The disturbance of human lymphocyte production of interleukin-2 and gamma-interferon during stress and the mechanisms of their interaction].
    Gotovtseva EP; Serov IV; Uchakin PN; Shestakova SV; Surkina ID; Ershov FI
    Vopr Virusol; 1990; 35(5):435-7. PubMed ID: 2125163
    [No Abstract]   [Full Text] [Related]  

  • 22. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
    Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q; Lefvert AK
    J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is pathogenic humoral autoimmunity a Th1 response?
    Saoudi A; Guery JC; De Baets M
    Immunol Today; 2000 Jun; 21(6):306-7. PubMed ID: 10825745
    [No Abstract]   [Full Text] [Related]  

  • 25. T-lymphocyte interferon-gamma receptor binding in patients with myasthenia gravis.
    Bongioanni P; Ricciardi R; Romano MR
    Arch Neurol; 1999 Aug; 56(8):933-8. PubMed ID: 10448798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type.
    Simpson JA; Behan PO; Dick HM
    Ann N Y Acad Sci; 1976; 274():382-9. PubMed ID: 134659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis and autoimmune theory].
    Uono M; Takaku F; Kano S; Wakabayashi Y
    Nihon Rinsho; 1973 Feb; 31(2):284-90. PubMed ID: 4737108
    [No Abstract]   [Full Text] [Related]  

  • 28. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myasthenia gravis and acetylcholine receptor].
    Abramsky O; Aharonov A; Tarrab-Hazdai R; Fuchs S
    Harefuah; 1975 Dec; 89(12):553-6. PubMed ID: 815144
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.
    Poussin MA; Goluszko E; David CS; Franco JU; Christadoss P
    J Autoimmun; 2001 Nov; 17(3):175-80. PubMed ID: 11712854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.
    Zisman E; Katz-Levy Y; Dayan M; Kirshner SL; Paas-Rozner M; Karni A; Abramsky O; Brautbar C; Fridkin M; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4492-7. PubMed ID: 8633096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of peripheral blood mononuclear cells from myasthenia gravis patients to exogenous interleukin-2.
    Ragheb S; Ferrio MF; Lisak RP
    Ann N Y Acad Sci; 1993 Jun; 681():323-4. PubMed ID: 8357182
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
    Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
    J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting.
    Hawke S; Matsuo H; Nicolle M; Malcherek G; Melms A; Willcox N
    Immunol Today; 1996 Jul; 17(7):307-11. PubMed ID: 8763815
    [No Abstract]   [Full Text] [Related]  

  • 38. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX; Ma CG; Xiao BG; van de Meide PH; Link H
    Eur J Immunol; 1996 Nov; 26(11):2552-8. PubMed ID: 8921938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
    Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.